These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11752683)

  • 1. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification.
    Kelly EJ; Erickson KE; Sengstag C; Eaton DL
    Toxicol Sci; 2002 Jan; 65(1):35-42. PubMed ID: 11752683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
    Fasullo M; Smith A; Egner P; Cera C
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apiaceous vegetable constituents inhibit human cytochrome P-450 1A2 (hCYP1A2) activity and hCYP1A2-mediated mutagenicity of aflatoxin B1.
    Peterson S; Lampe JW; Bammler TK; Gross-Steinmeyer K; Eaton DL
    Food Chem Toxicol; 2006 Sep; 44(9):1474-84. PubMed ID: 16762476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms.
    Eaton DL; Bammler TK; Kelly EJ
    Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regiospecific expression of cytochrome P-450s and microsomal epoxide hydrolase in human brain tissue.
    Farin FM; Omiecinski CJ
    J Toxicol Environ Health; 1993; 40(2-3):317-35. PubMed ID: 7693960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
    Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
    Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B(1).
    Klein PJ; Buckner R; Kelly J; Coulombe RA
    Toxicol Appl Pharmacol; 2000 May; 165(1):45-52. PubMed ID: 10814552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
    Van Vleet TR; Klein PJ; Coulombe RA
    J Toxicol Environ Health A; 2002 Jun; 65(12):853-67. PubMed ID: 12079611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K; Eaton DL
    Toxicology; 2012 Sep; 299(2-3):69-79. PubMed ID: 22640941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes.
    Sengstag C; Würgler FE
    Mol Carcinog; 1994 Dec; 11(4):227-35. PubMed ID: 7999264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C; Eugster HP; Würgler FE
    Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity of aflatoxin B1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae.
    Sengstag C; Weibel B; Fasullo M
    Cancer Res; 1996 Dec; 56(23):5457-65. PubMed ID: 8968101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cellular responses to aflatoxin B(1) in yeast expressing human cytochrome P450 1A2 using cDNA microarrays.
    Guo Y; Breeden LL; Fan W; Zhao LP; Eaton DL; Zarbl H
    Mutat Res; 2006 Jan; 593(1-2):121-42. PubMed ID: 16122766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.
    Doi AM; Patterson PE; Gallagher EP
    Toxicol Appl Pharmacol; 2002 May; 181(1):48-59. PubMed ID: 12030842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
    Walters JM; Combes RD
    Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 enzymes involved in the metabolism of aflatoxin B1 in chickens and quail.
    Diaz GJ; Murcia HW; Cepeda SM
    Poult Sci; 2010 Nov; 89(11):2461-9. PubMed ID: 20952710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
    Van Vleet TR; Macé K; Coulombe RA
    Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.